William Lis Jasper Therapeutics, Inc. (JSPR) insider trading activity

William Lis is Director of Jasper Therapeutics, Inc.. Currently has a direct ownership of 53,521 shares of JSPR, which is worth approximately $1.39 Million. The most recent transaction as insider was on Oct 13, 2023, when has been sold 7,965 shares (Voting Common Stock) at a price of $0.85 per share, resulting in proceeds of $6,770. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.5K

0% 3M change

12.95% 12M change

Total Value Held $1.39 Million

William Lis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 13 2023	SELL Open market or private sale	$6,770 $0.85 p/Share	7,965 Reduced 12.95%	53,521 Voting Common Stock
Apr 13 2023	SELL Open market or private sale	$12,240 $1.44 p/Share	8,500 Reduced 12.15%	61,486 Voting Common Stock
Oct 12 2022	BUY Grant, award, or other acquisition	-	29,500 Added 29.65%	69,986 Voting Common Stock
Jun 27 2022	SELL Open market or private sale	$51,465 $2.08 p/Share	24,743 Reduced 37.93%	40,486 Voting Common Stock
Jun 24 2022	SELL Open market or private sale	$49,981 $2.02 p/Share	24,743 Reduced 27.5%	65,229 Voting Common Stock
Mar 21 2022	BUY Grant, award, or other acquisition	-	89,972 Added 50.0%	89,972 Voting Common Stock

Also insider at

ZLAB

Zai Lab Ltd Healthcare

EIDX

Eidos Therapeutics, Inc.

Director

William Lis

Director

Pudong, Shanghai, F4

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JSPR shares.

Notify only if

Value

Insider Trading

Get notified when an Jasper Therapeutics, Inc. insider buys or sells JSPR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jasper Therapeutics, Inc.

Track Activities on JSPR

Account